Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

NCT06849544 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Surgery
Prostate Cancer Metastatic Disease

Interventions

DRUG: 0.03mg/kg ZOPOCIANINE given day of surgery
DRUG: 0.06mg/kg ZOPOCIANINE given day of surgery
DRUG: 0.03mg/kg ZOPOCIANINE given day prior to surgery
DRUG: 0.06mg/kg ZOPOCIANINE given days prior to surgery

Sponsor

Clinton Bahler

Collaborators

[object Object]
[object Object]